Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer+2

Recruiting

Registered drugNo placebo

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Breast cancer metastatic

Recruiting

InvestigationalNo placebo

Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Chronic lymphocytic leukaemia+1

Recruiting

Registered drugNo placebo

Study on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Obesity+1

Not yet recruiting

Investigational

Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Diabetes mellitus+2

Not yet recruiting

Investigational

A Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Myelofibrosis

Not recruiting

Registered drugNo placebo

Study of RVU120 and Ruxolitinib for Patients with Intermediate or High-Risk Myelofibrosis

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Ruxolitinib

Contact Research Centre

Acute myeloid leukaemia+1

Not recruiting

InvestigationalNo placebo

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride

Contact Research Centre

Small cell lung cancer extensive stage

Not recruiting

Registered drug

Study on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Glucose Monohydrate

Contact Research Centre

Atrial fibrillation

Not recruiting

Registered drug

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Andexanet Alfa

Contact Research Centre

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Not recruiting

Registered drugNo placebo

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Acute myocardial infarction

Not recruiting

Investigational

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ziltivekimab

Contact Research Centre

Renal cancer metastatic

Not recruiting

Registered drugNo placebo

Study of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Find therapies in clinical trials near you – page 2

34 trials match your criteria

Non-small cell lung cancer+2

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Breast cancer metastatic

Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

Chronic lymphocytic leukaemia+1

Study on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia

Obesity+1

Efficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial

Diabetes mellitus+2

A Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes

Myelofibrosis

Study of RVU120 and Ruxolitinib for Patients with Intermediate or High-Risk Myelofibrosis

Acute myeloid leukaemia+1

Study of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Small cell lung cancer extensive stage

Study on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer

Atrial fibrillation

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Acute myocardial infarction

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Renal cancer metastatic

Study of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.